FOPAL
Summary of public USPTO data
- Owner
- Clementia Pharmaceuticals Inc.
- Status
- Live/Registered
- Serial number
- 97623952
- Registration number
- 8497999
- Filing date
- 2022-10-07
- Registration date
- 2026-10-13
- International classes
- 35, 42, 44
Goods and services
Class 35
- Maintaining a registry of patient data and medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment
- conducting business and market research surveys in the fields of pharmaceuticals and clinical trials
Class 42
- Providing a website featuring medical and scientific research educational information in the fields of pharmaceuticals and clinical trials
- providing medical and scientific research information in the field of Fibrodysplasia ossificans progressiva (FOP) disease and treatment
Class 44
- Providing an online computer database featuring a compilation of medical information and patient records being medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment
- medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment
- medical assistance services, namely, providing support in the observation, monitoring, adherence and medical treatments on patients in the field of Fibrodysplasia ossificans progressiva (FOP) disease
- health assessment services, namely, conducting health-related surveys and questionnaires that produce medical treatment information
- conducting medical information surveys and questionnaires in the fields of disease and treatment, namely, conducting health surveys of patients with Fibrodysplasia ossificans progressiva (FOP) disease for medical purposes